Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Royer

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2025
Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain AmyloidosisMartin Nicol, Camille Cohen, Alexis Talbot, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2018
The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departmentsOmar Benbrahim, Jean-François Viallard, Sylvain Choquet, et al.
American Journal of Hematology|April 27, 2013
5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapySarah Ivanoff, Berengere Gruson, Sylvain P Chantepie, et al.
Immunology and Cell Biology|May 7, 2014
Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cellsHussein Ghamlouch, Hakim Ouled-Haddou, Aude Guyart, et al.
Frontiers in Immunology|July 2, 2014
TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting CellsHussein Ghamlouch, Hakim Ouled-Haddou, Aude Guyart, et al.
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
Oncotarget|June 8, 2015
Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cellsHussein Ghamlouch, Walaa Darwiche, Ahmed Hodroge, et al.
La Revue De Medecine Interne|August 8, 2024
[Serum hyperviscosity syndrome: Update 2024]Pierre-Edouard Debureaux, Nathalie Parquet, Anne C Brignier, et al.
Haematologica|July 3, 2025
Teclistamab for heavily pretreated relapsed / refractory POEMS syndromeAlexis Talbot, Nathalie Forgeard, Tristan Vaugeois, et al.
Immunotherapy|August 21, 2025
Gamma heavy chain disease treated with daratumumab-based regimen: a first case report and review of literatureCarla Cicerchia, Tristan Vaugeois, Nathalie Forgeard, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 21, 2025
Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain AmyloidosisMartin Nicol, Camille Cohen, Alexis Talbot, et al.
Hematology (Amsterdam, Netherlands)|November 22, 2018
The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departmentsOmar Benbrahim, Jean-François Viallard, Sylvain Choquet, et al.
American Journal of Hematology|April 27, 2013
5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapySarah Ivanoff, Berengere Gruson, Sylvain P Chantepie, et al.
Immunology and Cell Biology|May 7, 2014
Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cellsHussein Ghamlouch, Hakim Ouled-Haddou, Aude Guyart, et al.
Frontiers in Immunology|July 2, 2014
TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting CellsHussein Ghamlouch, Hakim Ouled-Haddou, Aude Guyart, et al.
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
Oncotarget|June 8, 2015
Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cellsHussein Ghamlouch, Walaa Darwiche, Ahmed Hodroge, et al.
La Revue De Medecine Interne|August 8, 2024
[Serum hyperviscosity syndrome: Update 2024]Pierre-Edouard Debureaux, Nathalie Parquet, Anne C Brignier, et al.
Haematologica|July 3, 2025
Teclistamab for heavily pretreated relapsed / refractory POEMS syndromeAlexis Talbot, Nathalie Forgeard, Tristan Vaugeois, et al.
Immunotherapy|August 21, 2025
Gamma heavy chain disease treated with daratumumab-based regimen: a first case report and review of literatureCarla Cicerchia, Tristan Vaugeois, Nathalie Forgeard, et al.
Pageof 11